nti_article_06

Linda Knight – Temple University

Dr. Knight is investigating the use of biocompatible nanoparticles as in vivo diagnostic imaging agents.  The nanoparticles are targeted to molecular markers of disease and are detectable by imaging methods such as magnetic resonance imaging.  It is hoped that disease-specific nanoparticles can be used to carry therapeutic agents as well as being used to provide initial diagnosis and monitoring of the progress of therapy.  This work is an outgrowth of Dr. Knight’s work on physiologic imaging using radiotracers.

 

For more information, please visit Dr. Knight’s website.

The Promise of Nanotechnology

“The use of nanotechnology in consumer products and industrial applications is growing rapidly, with the products listed in the inventory showing just the tip of the iceberg.  How consumers respond to these early products — in food, electronics, health care, clothing and cars — will be a litmus test for broader market acceptance of nanotechnologies in the future.”

–Andrew D. Maynard
Chief Science Advisor, Project on Emerging Nanotechnologies
Woodrow Wilson International Center for Scholars